With rates of obesity in Ireland rising, Dr Grace O’Malley, clinical lead for the CHI child and adolescent obesity service, ...

Weight-loss surgeries for adolescents increased 15% in the U.S. between 2021 and 2023, even as the Food and Drug ...

New UK research reveals that obesity significantly worsens pain, mobility, and daily functioning in older adults with knee ...

Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity treatment more than tripled among US adults without diabetes between 2018 and ...

Metabolic syndrome components were associated with higher odds of sleep apnea symptoms among adolescents and young adults in the US.

Currently, more than 42% of adults in the United States have obesity. Among young people, about 1 in 5 adolescents are also ...

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

A decision is expected in the fourth quarter of 2025.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...